GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.

Income Statement Guizhou Bailing Group Pharmaceutical Co., Ltd.

Stocks

002424

CNE100000PY3

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2026-08-25			5-day change	1st Jan Change
4.580 ^CNY	+0.66%		+0.44%	+5.29%

08-24	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-22	Guizhou Bailing's Three Products Chosen for China's Centralized Procurement for Traditional Medicine	MT

8bc.QqgL_3Ap5RVbeco-ot3I1ZQx5Prtka5l9R6vTyOW2FU.delBmSB9gnABMJVS4ISM5K1hip2svN5Xj3j7NnzvqCJ15CagP1DIJjcx-g

Published financial data: GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.08B	3.53B	4.26B	3.81B	3.04B
Other Revenues, Total	31.6M	10.4M	7.31M	14.42M	11.87M
Total Revenues	3.11B	3.54B	4.26B	3.83B	3.05B
Cost of Goods Sold, Total	1.27B	1.44B	1.95B	1.66B	1.66B
Gross Profit	1.85B	2.1B	2.31B	2.17B	1.39B
Selling General & Admin Expenses, Total	1.48B	1.75B	2.56B	2.08B	1.22B
Provision for Bad Debts	66.48M	80.94M	70.23M	47.48K	3.26M
R&D Expenses	30.43M	22.4M	42.04M	23.1M	17.96M
Other Operating Expenses	39.14M	49.21M	40.29M	39.89M	38.19M
Other Operating Expenses, Total	1.62B	1.9B	2.71B	2.15B	1.28B
Operating Income	229M	203M	-402M	19.62M	108M
Interest Expense, Total	-116M	-102M	-92.71M	-85.83M	-61.78M
Interest And Investment Income	3.74M	31.33M	6.54M	24.93M	634K
Net Interest Expenses	-113M	-70.32M	-86.17M	-60.9M	-61.15M
Currency Exchange Gains (Loss)	56.57K	1	1	-	-
Other Non Operating Income (Expenses)	-866K	-4.36M	-15.71M	34.69M	-11.66M
EBT, Excl. Unusual Items	116M	128M	-504M	-6.59M	35.19M
Gain (Loss) On Sale Of Investments	58.53M	9.64M	-4.3M	-35.07M	-31.5M
Gain (Loss) On Sale Of Assets	-471K	-298K	1.14M	-137K	18.12M
Asset Writedown	-921K	-91.21K	146K	-124K	-5.58M
Other Unusual Items	-25.55M	21.54M	14.17M	109M	24.23M
EBT, Incl. Unusual Items	148M	159M	-493M	66.91M	40.47M
Income Tax Expense	31.07M	23.09M	-80.61M	30.14M	144M
Earnings From Continuing Operations	117M	136M	-412M	36.77M	-103M
Net Income to Company	117M	136M	-412M	36.77M	-103M
Minority Interest	7.52M	2.23M	-2.05M	-3.14M	-1.24M
Net Income - (IS)	124M	138M	-415M	33.62M	-104M
Net Income to Common Incl Extra Items	124M	138M	-415M	33.62M	-104M
Net Income to Common Excl. Extra Items	124M	138M	-415M	33.62M	-104M
Per Share Items
Net EPS - Basic	0.09	0.1	-0.3	0.02	-0.08
Basic EPS - Continuing Operations	0.09	0.1	-0.3	0.02	-0.08
Basic Weighted Average Shares Outstanding	1.38B	1.38B	1.38B	1.68B	1.3B
Net EPS - Diluted	0.09	0.1	-0.3	0.02	-0.08
Diluted EPS - Continuing Operations	0.09	0.1	-0.3	0.02	-0.08
Diluted Weighted Average Shares Outstanding	1.38B	1.38B	1.38B	1.68B	1.3B
Normalized Basic EPS	0.06	0.06	-0.23	-0	0.02
Normalized Diluted EPS	0.06	0.06	-0.23	-0	0.02
Dividend Per Share	-	-	-	-	-
Payout Ratio	80.66	62.63	-19.43	241.94	-59.86
Supplemental Items
EBITDA	324M	306M	-299M	124M	222M
EBITA	244M	219M	-390M	26.68M	115M
EBIT	229M	203M	-402M	19.62M	108M
EBITDAR	331M	312M	-293M	131M	233M
Total Revenues (As Reported)	3.11B	3.54B	4.26B	3.83B	3.05B
Effective Tax Rate - (Ratio)	21.03	14.51	16.35	45.05	354.8
Current Domestic Taxes	32.35M	35.54M	26.5M	52.91M	97.77M
Total Current Taxes	32.35M	35.54M	26.5M	52.91M	97.77M
Deferred Domestic Taxes	-1.28M	-12.46M	-107M	-22.77M	45.83M
Total Deferred Taxes	-1.28M	-12.46M	-107M	-22.77M	45.83M
Normalized Net Income	80.12M	82.39M	-317M	-7.27M	20.75M
Interest on Long-Term Debt	475K	355K	-	-	-
Supplemental Operating Expense Items
Advertising Expense	142M	-	-	-	-
Marketing Expenses	681M	1.01B	1.69B	-	588M
Selling and Marketing Expenses	1.29B	1.53B	2.31B	1.85B	1.01B
General and Administrative Expenses	192M	217M	249M	229M	212M
Research And Development Expense From Footnotes	35.74M	27.4M	43.58M	24.64M	19.5M
Net Rental Expense, Total	7.16M	5.93M	5.61M	7.23M	10.7M
Imputed Operating Lease Interest Expense	3.34M	2.96M	2.56M	2.85M	3.5M
Imputed Operating Lease Depreciation	3.81M	2.97M	3.05M	4.38M	7.2M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	466M	605M	418M	396M	355M
Total Cash And Short Term Investments	466M	605M	418M	396M	355M
Accounts Receivable, Total	1.98B	2.21B	2.2B	1.95B	1.58B
Other Receivables	197M	153M	160M	70.57M	58.04M
Total Receivables	2.18B	2.36B	2.36B	2.02B	1.63B
Inventory	845M	805M	1.16B	1.11B	666M
Other Current Assets, Total	42.32M	49.71M	70.2M	112M	69.6M
Total Current Assets	3.53B	3.82B	4.01B	3.64B	2.72B
Gross Property Plant And Equipment	1.62B	1.8B	2.03B	2.27B	2.31B
Accumulated Depreciation	-656M	-736M	-838M	-894M	-982M
Net Property Plant And Equipment	964M	1.06B	1.19B	1.37B	1.33B
Long-term Investments	1.47B	1.45B	1.44B	1.34B	1.38B
Goodwill	20.58M	20.58M	21.38M	21.38M	21.38M
Other Intangibles, Total	215M	205M	197M	208M	194M
Deferred Tax Assets Long-Term	55.27M	82.67M	192M	231M	185M
Deferred Charges Long-Term	149M	147M	182M	215M	243M
Other Long-Term Assets, Total	82.17M	109M	112M	107M	125M
Total Assets	6.49B	6.89B	7.35B	7.13B	6.2B
Liabilities
Accounts Payable, Total	404M	581M	905M	783M	765M
Accrued Expenses, Total	98.38M	132M	862M	1.09B	757M
Short-term Borrowings	1.45B	1.48B	1.44B	1.43B	1.02B
Current Portion of Long-Term Debt	202M	-	500K	285M	50.06M
Current Portion of Leases	8.35M	12.15M	10.57M	8.15M	7M
Current Income Taxes Payable	14.44M	13.99M	8.4M	9.86M	6.21M
Unearned Revenue Current, Total	46.17M	156M	92.75M	75.58M	72.51M
Other Current Liabilities	134M	393M	201M	118M	122M
Total Current Liabilities	2.35B	2.77B	3.52B	3.8B	2.8B
Long-Term Debt	-	-	200M	49.06M	139M
Long-Term Leases	57.66M	47.28M	39.46M	21.95M	13.96M
Unearned Revenue Non Current	23.4M	22.38M	34.96M	61.29M	67.16M
Deferred Tax Liability Non Current	28.81M	32.17M	31.08M	3.6M	3.39M
Other Non Current Liabilities	64.68M	27.25M	-	-	-
Total Liabilities	2.53B	2.9B	3.82B	3.94B	3.02B
Common Stock, Total	1.41B	1.41B	1.41B	1.4B	1.4B
Additional Paid In Capital	159M	141M	174M	87.45M	166M
Retained Earnings	2.47B	2.54B	2.13B	1.92B	1.81B
Treasury Stock	-100M	-100M	-200M	-220M	-220M
Comprehensive Income and Other	77.56K	51.04K	70.19K	26.36K	-37.32K
Total Common Equity	3.94B	3.99B	3.51B	3.18B	3.16B
Minority Interest	18.9M	2.27M	14.89M	18.04M	19.28M
Total Equity	3.96B	4B	3.53B	3.2B	3.17B
Total Liabilities And Equity	6.49B	6.89B	7.35B	7.13B	6.2B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.4B	1.4B	1.39B	1.37B	1.37B
ECS Total Common Shares Outstanding	1.4B	1.4B	1.39B	1.37B	1.37B
Book Value / Share	2.82	2.86	2.54	2.33	2.31
Tangible Book Value	3.71B	3.77B	3.29B	2.95B	2.94B
Tangible Book Value Per Share	2.65	2.7	2.38	2.16	2.15
Total Debt	1.72B	1.54B	1.69B	1.8B	1.23B
Net Debt	1.25B	935M	1.27B	1.4B	875M
Debt Equivalent Oper. Leases	57.24M	47.47M	44.88M	57.88M	85.59M
Minority Interest, Total (Incl. Fin. Div)	18.9M	2.27M	14.89M	18.04M	19.28M
Equity Method Investments, Total	1.11B	1.08B	1.09B	994M	1.04B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	420M	440M	478M	583M	395M
Inventories - Work In Process, Total	86.23M	113M	201M	149M	74.62M
Inventories - Finished Goods, Total	354M	285M	556M	498M	265M
Buildings, Total	750M	747M	749M	939M	1.17B
Machinery, Total	673M	757M	907M	922M	993M
Full Time Employees	6.12K	6.14K	6.58K	6.59K	5.72K
Accumulated Allowance for Doubtful Accounts (Supple)	328M	378M	365M	218M	198M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	124M	138M	-415M	33.62M	-104M
Depreciation & Amortization - CF	91.62M	99.76M	103M	108M	115M
Amortization of Goodwill and Intangible Assets - (CF)	14.9M	15.75M	12.37M	7.05M	7.06M
Depreciation & Amortization, Total	107M	116M	116M	115M	122M
Amortization of Deferred Charges, Total - (CF)	7.26M	7.98M	8.66M	9.52M	9.85M
(Gain) Loss From Sale Of Asset	471K	298K	-1.14M	137K	-18.12M
(Gain) Loss on Sale of Investments - (CF)	-58.53M	-38.73M	4.3M	34.69M	31.5M
Asset Writedown & Restructuring Costs	921K	91.21K	-146K	23.22M	5.58M
Provision and Write-off of Bad Debts	66.48M	80.94M	70.23M	-	3.26M
Other Operating Activities, Total	106M	118M	151M	88.98M	128M
Change In Accounts Receivable	194M	-183M	-34.97M	477M	383M
Change In Inventories	-63.22M	8.74M	-397M	-4.2M	392M
Change In Accounts Payable	-112M	220M	735M	-747M	-249M
Change In Deferred Taxes	-1.28M	-12.46M	-111M	-22.77M	45.83M
Change in Other Net Operating Assets	-46.12M	46.12M	-	-	-
Cash from Operations	325M	502M	126M	9.02M	749M
Capital Expenditure	-426M	-68.45M	-104M	-42.02M	-125M
Sale of Property, Plant, and Equipment	123K	782K	1.46M	55.02K	23.89M
Cash Acquisitions	-	-	-3.92M	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-162M	80.75M	63.32M	134M	-4.74M
Net (Increase) Decrease in Loans Originated / Sold - Investing	348M	-	-300K	-	-
Other Investing Activities, Total	282M	7.36M	8.73M	-11.32M	11.32M
Cash from Investing	42.59M	20.44M	-34.83M	80.52M	-94.78M
Short Term Debt Issued, Total	-	1.48B	-	-	-
Long-Term Debt Issued, Total	1.64B	-	1.7B	1.63B	1.17B
Total Debt Issued	1.64B	1.48B	1.7B	1.63B	1.17B
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-2.2B	-1.71B	-1.73B	-1.6B	-1.74B
Total Debt Repaid	-2.2B	-1.71B	-1.73B	-1.6B	-1.74B
Issuance of Common Stock	-	1.6M	-	-	-
Repurchase of Common Stock	-100M	-	-100M	-120M	-
Common Dividends Paid	-100M	-86.55M	-80.54M	-81.35M	-62.48M
Common & Preferred Stock Dividends Paid	-100M	-86.55M	-80.54M	-81.35M	-62.48M
Other Financing Activities, Total	-	800K	430K	-	-
Cash from Financing	-766M	-315M	-215M	-169M	-636M
Foreign Exchange Rate Adjustments	-19	11	-7	17	24
Net Change in Cash	-399M	207M	-124M	-79.5M	17.5M
Supplemental Items
Cash Income Tax Paid (Refund)	311M	370M	455M	399M	325M
Levered Free Cash Flow	155M	452M	123M	107M	563M
Unlevered Free Cash Flow	228M	516M	181M	160M	601M
Change In Net Working Capital	-397M	-334M	-413M	-65.06M	-527M
Net Debt Issued / Repaid	-566M	-231M	-34.69M	31.89M	-574M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.12	1.9	-3.53	0.17	1.01
Return on Total Capital	2.42	2.28	-4.67	0.25	1.44
Return On Equity %	2.96	3.45	-10.96	1.13	-3.24
Return on Common Equity	3.17	3.51	-11.04	1.04	-3.29
Margin Analysis
Gross Profit Margin %	59.34	59.39	54.19	56.61	45.63
SG&A Margin	47.59	49.35	60.05	54.45	40.13
EBITDA Margin %	10.42	8.63	-7	3.24	7.28
EBITA Margin %	7.85	6.18	-9.15	0.7	3.77
EBIT Margin %	7.38	5.73	-9.44	0.51	3.54
Income From Continuing Operations Margin %	3.75	3.84	-9.68	0.96	-3.38
Net Income Margin %	3.99	3.9	-9.72	0.88	-3.42
Net Avail. For Common Margin %	3.99	3.9	-9.72	0.88	-3.42
Normalized Net Income Margin	2.57	2.33	-7.44	-0.19	0.68
Levered Free Cash Flow Margin	4.99	12.77	2.89	2.79	18.45
Unlevered Free Cash Flow Margin	7.33	14.57	4.25	4.19	19.72
Asset Turnover
Asset Turnover	0.46	0.53	0.6	0.53	0.46
Fixed Assets Turnover	3.78	3.49	3.79	2.99	2.26
Receivables Turnover (Average Receivables)	1.51	1.69	1.93	1.83	1.72
Inventory Turnover (Average Inventory)	1.55	1.76	1.98	1.46	1.87
Short Term Liquidity
Current Ratio	1.5	1.38	1.14	0.96	0.97
Quick Ratio	1.12	1.07	0.79	0.64	0.71
Operating Cash Flow to Current Liabilities	0.14	0.18	0.04	0	0.27
Days Sales Outstanding (Average Receivables)	241.82	216.53	189.1	199.57	212.09
Days Outstanding Inventory (Average Inventory)	234.85	206.92	183.97	250.82	195.65
Average Days Payable Outstanding	132.37	126.86	117.32	192.15	233
Cash Conversion Cycle (Average Days)	344.29	296.6	255.75	258.24	174.73
Long Term Solvency
Total Debt/Equity	43.31	38.53	47.81	56.14	38.73
Total Debt / Total Capital	30.22	27.81	32.34	35.95	27.92
LT Debt/Equity	1.46	1.18	6.78	2.22	4.81
Long-Term Debt / Total Capital	1.02	0.85	4.59	1.42	3.46
Total Liabilities / Total Assets	38.97	42.03	52	55.16	48.77
EBIT / Interest Expense	1.97	2	-4.34	0.23	1.75
EBITDA / Interest Expense	2.89	3.13	-3.09	1.57	3.72
(EBITDA - Capex) / Interest Expense	-0.77	2.46	-4.22	1.08	1.7
Total Debt / EBITDA	5.1	4.84	-5.88	13.3	5.35
Net Debt / EBITDA	3.72	2.94	-4.42	10.37	3.8
Total Debt / (EBITDA - Capex)	-19.12	6.16	-4.31	19.3	11.73
Net Debt / (EBITDA - Capex)	-13.93	3.74	-3.24	15.05	8.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.77	13.79	20.42	-10.26	-20.31
Gross Profit, 1 Yr. Growth %	6.52	14.29	9.88	-6.26	-35.77
EBITDA, 1 Yr. Growth %	10.64	-3.9	-191.38	-141.7	76.85
EBITA, 1 Yr. Growth %	15.52	-8.2	-262.6	-106.86	310.16
EBIT, 1 Yr. Growth %	16.77	-8.93	-280.08	-104.88	450.39
Earnings From Cont. Operations, 1 Yr. Growth %	-24.09	24.14	-402.73	-108.91	-380.49
Net Income, 1 Yr. Growth %	-18.49	16.64	-399.34	-108.11	-410.41
Normalized Net Income, 1 Yr. Growth %	-4.31	43.84	-479.73	-97.71	-385.63
Diluted EPS Before Extra, 1 Yr. Growth %	-18.18	25	-400	-106.67	-500
Accounts Receivable, 1 Yr. Growth %	-5.7	11.44	-0.23	-11.29	-19.37
Inventory, 1 Yr. Growth %	7.82	-2.46	44.59	-4.5	-40.08
Net Property, Plant and Equip., 1 Yr. Growth %	41.16	10.3	11.8	15.48	-3.16
Total Assets, 1 Yr. Growth %	-7.73	6.5	6.59	-3.48	-13.14
Tangible Book Value, 1 Yr. Growth %	-0.91	3.56	-12.59	-3.19	-0.39
Common Equity, 1 Yr. Growth %	1.22	3.09	-12.05	-2.63	-0.81
Cash From Operations, 1 Yr. Growth %	-40.32	54.55	-74.95	-92.83	8.2K
Capital Expenditures, 1 Yr. Growth %	372.9	-83.92	52.1	-59.64	198.07
Levered Free Cash Flow, 1 Yr. Growth %	-47.02	83.95	-73.49	-74.15	427.61
Unlevered Free Cash Flow, 1 Yr. Growth %	-39.24	61.93	-65.72	-65.87	275.1
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.48	7.07	17.06	3.95	-15.43
Gross Profit, 2 Yr. CAGR %	4.04	10.14	12.06	1.49	-22.41
EBITDA, 2 Yr. CAGR %	-21.55	2.13	-3.1	-38.38	-13.65
EBITA, 2 Yr. CAGR %	-26.55	1.67	27.94	-66.65	-45.61
EBIT, 2 Yr. CAGR %	-27.63	1.62	34.37	-70.36	-48.19
Earnings From Cont. Operations, 2 Yr. CAGR %	-35.96	-5.95	94.05	-48.05	-50
Net Income, 2 Yr. CAGR %	-33.72	-4.77	87.04	-50.72	-49.82
Normalized Net Income, 2 Yr. CAGR %	-42	-0.81	135.31	-70.51	-74.42
Diluted EPS Before Extra, 2 Yr. CAGR %	-32.92	-4.65	93.65	-55.28	-48.36
Accounts Receivable, 2 Yr. CAGR %	-5.04	2.51	5.45	-5.92	-15.42
Inventory, 2 Yr. CAGR %	-8.4	1.35	18.76	17.51	-24.36
Net Property, Plant and Equip., 2 Yr. CAGR %	14.55	24.78	11.05	13.63	5.75
Total Assets, 2 Yr. CAGR %	-4.05	-0.99	6.55	1.73	-8.44
Tangible Book Value, 2 Yr. CAGR %	-1.84	0.39	-4.87	-11.5	-1.8
Common Equity, 2 Yr. CAGR %	-1.37	1.29	-4.79	-10.75	-1.72
Cash From Operations, 2 Yr. CAGR %	-16.62	-3.96	-37.79	-86.6	143.99
Capital Expenditures, 2 Yr. CAGR %	86.88	-12.8	-50.55	-21.65	9.68
Levered Free Cash Flow, 2 Yr. CAGR %	-11.97	24.18	-29.19	-52.11	16.79
Unlevered Free Cash Flow, 2 Yr. CAGR %	-8.1	17.23	-24.57	-44.93	13.14
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.27	7.49	11.35	7.13	-4.86
Gross Profit, 3 Yr. CAGR %	-0.5	7.22	10.05	5.59	-12.87
EBITDA, 3 Yr. CAGR %	-23.86	-16.6	0.63	-26.93	-12.11
EBITA, 3 Yr. CAGR %	-28.47	-21.55	22.61	-51.8	-21.72
EBIT, 3 Yr. CAGR %	-29.48	-22.63	26.97	-55.51	-21.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-41.12	-21.82	38.96	-30.5	-8.87
Net Income, 3 Yr. CAGR %	-39.58	-21.23	39.6	-34.29	-9
Normalized Net Income, 3 Yr. CAGR %	-41.57	-29.8	55.88	-49.76	-37.13
Diluted EPS Before Extra, 3 Yr. CAGR %	-38.66	-20.63	39.71	-37	-7.17
Accounts Receivable, 3 Yr. CAGR %	-5.41	0.16	1.59	-0.46	-10.64
Inventory, 3 Yr. CAGR %	-0.94	-7.2	14.09	10.43	-6.12
Net Property, Plant and Equip., 3 Yr. CAGR %	8.77	13.11	20.29	12.51	7.73
Total Assets, 3 Yr. CAGR %	2.78	-0.74	1.48	3.29	-3.49
Tangible Book Value, 3 Yr. CAGR %	0.12	-0.67	-4.15	-6.75	-7.94
Common Equity, 3 Yr. CAGR %	0.61	-0.47	-3.38	-6.36	-7.55
Cash From Operations, 3 Yr. CAGR %	27.32	2.42	-38.64	-69.72	14.24
Capital Expenditures, 3 Yr. CAGR %	48.88	-17.5	4.97	-53.79	22.31
Levered Free Cash Flow, 3 Yr. CAGR %	-31.73	31.14	-25.09	-24.3	6.56
Unlevered Free Cash Flow, 3 Yr. CAGR %	-20.73	24.08	-21.55	-20.46	4.39
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.04	6.43	6.33	6.06	-0.26
Gross Profit, 5 Yr. CAGR %	5.4	5.12	4.27	4.89	-4.3
EBITDA, 5 Yr. CAGR %	-13.2	-14.65	-16.47	-25.11	-5.41
EBITA, 5 Yr. CAGR %	-16.33	-18.66	-10.2	-43.25	-11.47
EBIT, 5 Yr. CAGR %	-17.02	-19.53	-9.27	-46.27	-11.28
Earnings From Cont. Operations, 5 Yr. CAGR %	-24.83	-23.88	-6.32	-33.59	-7.67
Net Income, 5 Yr. CAGR %	-23.76	-23.46	-5.95	-34.68	-7.29
Normalized Net Income, 5 Yr. CAGR %	-25.9	-25.87	-4.61	-50.24	-24.35
Diluted EPS Before Extra, 5 Yr. CAGR %	-23.34	-23.02	-5.11	-36.9	-6.17
Accounts Receivable, 5 Yr. CAGR %	10.22	6.21	-1.21	-2.32	-5.59
Inventory, 5 Yr. CAGR %	4.42	-0.52	6.01	1.99	-3.2
Net Property, Plant and Equip., 5 Yr. CAGR %	7.36	8.14	9.68	13.32	14.25
Total Assets, 5 Yr. CAGR %	8.91	7.41	4.22	0.24	-2.5
Tangible Book Value, 5 Yr. CAGR %	5.52	3.11	-2.26	-5.16	-4.7
Common Equity, 5 Yr. CAGR %	5.46	3.16	-1.92	-4.72	-4.12
Cash From Operations, 5 Yr. CAGR %	-6.98	36.5	-4.39	-54.59	6.58
Capital Expenditures, 5 Yr. CAGR %	21.72	-13.9	-4.2	-19.19	6.83
Levered Free Cash Flow, 5 Yr. CAGR %	-3.11	13.89	-24.06	-11.86	13.92
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.12	19.33	-16.92	-9.9	9.88
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-